On December 2018, one of the most important american HIV/AIDS magazines, A&U – America’s AIDS Magazine, wrote about the new HIV cure research strategies. The article written by columnist Jeannie Wraight, pointed out the need for a not only efficacious but also affordable HIV cure, introducing consequently First Health Pharmaceuticals‘ cutting edge antiretroviral research that consists in a new class of drug, the RNA helicase Translation Inhibitors targeting a human host factor called DDX3.
Read the full article below
Loading...
Reload document 
Open in new tab